SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,428 | +1.7% | 20,400 | +10.9% | 0.01% | +20.0% |
| Q2 2023 | $553,104 | +50.7% | 18,400 | +46.0% | 0.01% | +66.7% |
| Q4 2021 | $367,000 | -40.9% | 12,600 | -45.9% | 0.00% | -50.0% |
| Q3 2021 | $621,000 | -30.0% | 23,300 | -19.1% | 0.01% | -33.3% |
| Q2 2021 | $887,000 | +9.0% | 28,800 | -7.4% | 0.01% | +12.5% |
| Q1 2021 | $814,000 | -8.3% | 31,100 | -11.9% | 0.01% | -11.1% |
| Q4 2020 | $888,000 | +8.4% | 35,300 | -10.2% | 0.01% | 0.0% |
| Q3 2020 | $819,000 | -15.0% | 39,300 | -3.2% | 0.01% | -18.2% |
| Q2 2020 | $964,000 | +20.3% | 40,600 | -8.8% | 0.01% | 0.0% |
| Q1 2020 | $801,000 | -24.1% | 44,500 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $1,056,000 | -13.4% | 44,500 | +0.2% | 0.01% | -21.4% |
| Q3 2019 | $1,220,000 | +43.5% | 44,400 | +72.8% | 0.01% | +40.0% |
| Q2 2019 | $850,000 | -28.9% | 25,700 | -24.6% | 0.01% | -28.6% |
| Q1 2019 | $1,195,000 | +10.6% | 34,100 | +4.9% | 0.01% | -6.7% |
| Q4 2018 | $1,080,000 | +30.0% | 32,500 | +97.0% | 0.02% | +50.0% |
| Q3 2018 | $831,000 | -39.1% | 16,500 | -27.6% | 0.01% | -41.2% |
| Q2 2018 | $1,365,000 | +0.4% | 22,800 | -23.2% | 0.02% | +6.2% |
| Q1 2018 | $1,360,000 | -26.9% | 29,700 | -36.4% | 0.02% | -27.3% |
| Q4 2017 | $1,861,000 | -10.5% | 46,700 | -10.2% | 0.02% | -12.0% |
| Q3 2017 | $2,080,000 | -29.2% | 52,000 | -23.8% | 0.02% | -32.4% |
| Q2 2017 | $2,939,000 | +30.8% | 68,200 | -5.0% | 0.04% | +27.6% |
| Q1 2017 | $2,247,000 | +45.2% | 71,800 | +17.1% | 0.03% | +31.8% |
| Q4 2016 | $1,548,000 | +9.8% | 61,300 | +7.5% | 0.02% | +10.0% |
| Q3 2016 | $1,410,000 | +502.6% | 57,000 | +395.7% | 0.02% | +566.7% |
| Q2 2016 | $234,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |